Loading...

Sartorius Stedim Biotech S.A.

DIM.PAEURONEXT
HealthcareMedical - Instruments & Supplies
193.65
-0.20(-0.10%)

Sartorius Stedim Biotech S.A. (DIM.PA) Stock Overview

Explore Sartorius Stedim Biotech S.A.’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
0.16%
0.16%
Profit Growth
2.10
43.46%
EPS Growth
2.10
46.13%
Operating Margin
15.61%
23.51%
ROE
5.19%
43.46%
Dividend Yield
0.00%
51.85%
Analyst Recommendations data is not available for DIM.PAAnalyst Recommendations details for DIM.PA are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, filtration, purification, and fluid management services; single-use and reusable hollow-fiber membrane devices, as well as presterilized assemblies for cell and gene therapy applications; and cell harvesting and various other solutions for intensified bioprocesses. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production. It serves manufacturers of pharmaceuticals, foods, and chemicals, as well as research and development laboratories. The company was founded in 1870 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.

CEO

Dr. Rene Faber

Employees

9,961

Headquarters

Zone Industrielle Les Paluds, Aubagne

Founded

2000

Frequently Asked Questions